• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙二醛酶I抑制剂二酯S-对溴苄基谷胱甘肽二乙酯的体外抗疟活性

Antimalarial activity in vitro of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester.

作者信息

Thornalley P J, Strath M, Wilson R J

机构信息

Department of Chemistry and Biological Chemistry, University of Essex, Colchester, U.K.

出版信息

Biochem Pharmacol. 1994 Jan 20;47(2):418-20. doi: 10.1016/0006-2952(94)90035-3.

DOI:10.1016/0006-2952(94)90035-3
PMID:8304987
Abstract

S-p-Bromobenzylglutathione diethyl ester induced toxicity in the malarial parasite Plasmodium falciparum in infected human red blood cells in culture. The median inhibitory concentration, IC50, was 4.77 +/- 0.12 microM (N = 10) for incorporation of [3H]hypoxanthine in nucleotide synthesis and 5.20 +/- 0.1 microM (N = 10) for incorporation of [14C]isoleucine into protein. The prospective mechanism of action is inhibition of glyoxalase I by the de-esterified metabolite, S-p-bromobenzylglutathione, and accumulation of the cytotoxic substrate methylglyoxal.

摘要

S-对溴苄基谷胱甘肽二乙酯在体外培养的受疟原虫恶性疟原虫感染的人类红细胞中诱导毒性。[3H]次黄嘌呤掺入核苷酸合成的半数抑制浓度(IC50)为4.77±0.12微摩尔(N = 10),[14C]异亮氨酸掺入蛋白质的IC50为5.20±0.1微摩尔(N = 10)。预期的作用机制是去酯化代谢产物S-对溴苄基谷胱甘肽对乙二醛酶I的抑制作用以及细胞毒性底物甲基乙二醛的积累。

相似文献

1
Antimalarial activity in vitro of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester.乙二醛酶I抑制剂二酯S-对溴苄基谷胱甘肽二乙酯的体外抗疟活性
Biochem Pharmacol. 1994 Jan 20;47(2):418-20. doi: 10.1016/0006-2952(94)90035-3.
2
Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro.乙二醛酶抑制剂二乙酯体外对人白血病60细胞增殖的抑制作用
Biochem Pharmacol. 1992 Dec 15;44(12):2357-63. doi: 10.1016/0006-2952(92)90680-h.
3
Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.紧密结合型乙二醛酶1抑制剂对恶性疟原虫感染的红细胞宿主-寄生虫单元的溶血和抗疟作用。
Redox Biol. 2016 Aug;8:348-53. doi: 10.1016/j.redox.2016.02.006. Epub 2016 Mar 2.
4
In vitro testing of a glyoxalase I inhibitor.乙二醛酶I抑制剂的体外测试
Biochem Soc Trans. 1993 May;21(2):157S. doi: 10.1042/bst021157s.
5
Inhibition of malaria-infected erythrocytes by deoxyspergualin: effect on in vitro growth of malarial cultures.脱氧精胍菌素对感染疟原虫红细胞的抑制作用:对疟原虫培养物体外生长的影响
Chemotherapy. 1998 Nov-Dec;44(6):409-13. doi: 10.1159/000007152.
6
Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione. The possible basis of a tumor-selective anticancer strategy.烯二醇类似物S-(N-羟基-N-甲基氨基甲酰)谷胱甘肽对乙二醛酶I的抑制作用。肿瘤选择性抗癌策略的可能基础。
J Biol Chem. 1992 Dec 15;267(35):24933-6.
7
Small molecule probes of glyoxalase I and glyoxalase II.乙二醛酶I和乙二醛酶II的小分子探针。
Biochim Biophys Acta. 1994 Sep 21;1208(1):127-35. doi: 10.1016/0167-4838(94)90169-4.
8
Probing the active site of glyoxalase I from human erythrocytes by use of the strong reversible inhibitor S-p-bromobenzylglutathione and metal substitutions.利用强可逆抑制剂S-对溴苄基谷胱甘肽和金属置换探究人红细胞乙二醛酶I的活性位点。
Biochem J. 1981 Jul 1;197(1):67-75. doi: 10.1042/bj1970067.
9
Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.从头嘧啶生物合成抑制剂对恶性疟原虫的细胞毒性作用。
Biochemistry. 1994 May 3;33(17):5268-74. doi: 10.1021/bi00183a033.
10
Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens.晶状体蛋白中的美拉德反应:甲基乙二醛介导的大鼠晶状体修饰。
Exp Eye Res. 2000 Mar;70(3):369-80. doi: 10.1006/exer.1999.0800.

引用本文的文献

1
Glyoxalase 2: Towards a Broader View of the Second Player of the Glyoxalase System.乙二醛酶2:对乙二醛酶系统第二个参与者的更全面认识
Antioxidants (Basel). 2022 Oct 28;11(11):2131. doi: 10.3390/antiox11112131.
2
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.新兴糖基化治疗学——醛糖还原酶 1 诱导剂和醛糖还原酶 1 抑制剂。
Int J Mol Sci. 2022 Feb 23;23(5):2453. doi: 10.3390/ijms23052453.
3
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒对蛋白毒性的易感性——COVID-19感染的化疗药物重新利用机会
Front Pharmacol. 2020 Oct 9;11:585408. doi: 10.3389/fphar.2020.585408. eCollection 2020.
4
Methylglyoxal couples metabolic and translational control of Notch signalling in mammalian neural stem cells.甲基乙二醛在哺乳动物神经干细胞中连接 Notch 信号的代谢和翻译控制。
Nat Commun. 2020 Apr 24;11(1):2018. doi: 10.1038/s41467-020-15941-2.
5
The cytosolic glyoxalases of are dispensable during asexual blood-stage development.在无性血液阶段发育过程中,疟原虫的胞质乙二醛酶是可有可无的。
Microb Cell. 2017 Nov 20;5(1):32-41. doi: 10.15698/mic2018.01.608.
6
Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance.新型恶性疟原虫代谢网络重建揭示了与临床抗疟药耐药性相关的转变。
BMC Genomics. 2017 Jul 19;18(1):543. doi: 10.1186/s12864-017-3905-1.
7
Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.紧密结合型乙二醛酶1抑制剂对恶性疟原虫感染的红细胞宿主-寄生虫单元的溶血和抗疟作用。
Redox Biol. 2016 Aug;8:348-53. doi: 10.1016/j.redox.2016.02.006. Epub 2016 Mar 2.
8
Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.疟原虫代谢网络的重建和通量平衡分析。
Mol Syst Biol. 2010 Sep 7;6:408. doi: 10.1038/msb.2010.60.
9
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.通过阶段特异性代谢网络分析预测恶性疟原虫中的抗疟药物靶点。
BMC Syst Biol. 2010 Aug 31;4:120. doi: 10.1186/1752-0509-4-120.
10
Metal-dependent inhibition of glyoxalase II: a possible mechanism to regulate the enzyme activity.金属依赖性抑制甘油醛-3-磷酸脱氢酶 II:一种调节酶活性的可能机制。
J Inorg Biochem. 2010 Jul;104(7):726-31. doi: 10.1016/j.jinorgbio.2010.03.005. Epub 2010 Mar 20.